NEW YORK (GenomeWeb) – Enzo Biochem said after the close of the market on Monday that its fiscal first quarter revenues grew 2 percent year over year, driven by an 8 percent spike in clinical laboratory services.

For the three months ended Oct. 31, the New York-based firm tallied $25.2 million in revenues compared to $24.8 million in the same quarter last year. Clinical lab revenues were $17.1 million compared to $15.8 million in fiscal Q1 2015, due to Enzo's continued focus on its menu of high-margin molecular assays.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.